Toxicological Studies of (212)Pb Intravenously or Intraperitoneally Injected into Mice for a Phase 1 Trial

por Milenic, Diane E., Molinolo, Alfredo A., Solivella, María S., Banaga, Eileen, Torgue, Julien, Besnainou, Sarah, Brechbiel, Martin W., Baidoo, Kwamena E.
Publicado 2015

Safety and Outcome Measures of First-in-Human Intraperitoneal α Radioimmunotherapy With (212)Pb-TCMC-Trastuzumab

por Meredith, Ruby F., Torgue, Julien J., Rozgaja, Tania A., Banaga, Eileen P., Bunch, Patty W., Alvarez, Ronald D., Straughn, J. Michael, Dobelbower, Michael C., Lowy, Andrew M.
Publicado 2018